PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients-Reference-Cited by-同舟云学术

PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients

Published:2022-01 Issue:1 Volume:239 Page:83-91
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Huang Jing,Xiao Jingmei,Peng Zhuang,Shao Ping,Sun Mengxi,Long Yujun,Wang Xiaoyi,Shen Manjun,Kang Dongyu,Yang Ye,Peng Xingjie,Wang Weiyan,Xie Peng,Shao Tiannan,Zhao Jingping,Wu Renrong

Funder

the National Nature Science Foundation of China

Innovative Research Group Project of the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s00213-021-06042-z.pdf

Reference30 articles.

1. Abifadel M, Rabès JP, Devillers M, Munnich A, Erlich D, Junien C, Varret M, Boileau C (2009) Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease. Hum Mutat 30:520–529

2. Abifadel M, Varret M, Rabès J-P, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34:154–156

3. Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M (2018) Molecular targets of atypical antipsychotics: from mechanism of action to clinical differences. Pharmacol Ther 192:20–41

4. Aringhieri S, Kolachalam S, Gerace C, Carli M, Verdesca V, Brunacci MG, Rossi C, Ippolito C, Solini A, Corsini GU, Scarselli M (2017) Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: role of 5-HT receptor agonism. Eur Neuropsychopharmacol 27:383–398

5. Bushe CJ, Taylor M, Haukka J (2010) Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol 24:17–25

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers;Metabolites;2024-01-23

2. Screening of the Key Genes and Signaling Pathways for Schizophrenia Using Bioinformatics and Next Generation Sequencing Data Analysis;2023-10-29

3. Effects of statin therapies on individuals taking antipsychotics: a systematic review;Journal of Cardiovascular Medicine;2023-05-02

4. Antipsychotic-Induced Alterations in Lipid Turnover;Endocrinology;2023-01-30

5. Drug–drug interactions involving combinations of antipsychotic agents with antidiabetic, lipid-lowering, and weight loss drugs;Expert Opinion on Drug Metabolism & Toxicology;2022-11-02